Articulate Biosciences, LLC
Articulate Biosciences, LLC, based in Lynnfield, MA, is a preclinical medical device development company spun out of Boston University in 2016. The company focuses on developing innovative injectable gels, known as ABX viscoelastics, aimed at treating arthritis and other soft tissue diseases, with an emphasis on restoring mobility and alleviating chronic joint pain.
Utilizing their patented ABX platform technology, Articulate Biosciences is dedicated to creating a portfolio of products for key indications in orthopedics and soft tissue repair. In addition to their internal product development, they offer technology product development services to clients in the musculoskeletal space, leveraging their expertise in polymeric biomaterials and drug formulations.
Generated from the website
You might also like
Partial Data by Infogroup (c) 2024. All rights reserved.